Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea

Gong Je Seong, Sae Heun Rho, Chang Sik Kim, Jong Il Moon, Michael Scott Kook, Yong Yeon Kim, Kyoung Tak Ma, Young Jae Hong, Lindsay A. Nelson, Bonnie Kruft, Jeanette A. Stewart, William C. Stewart

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: The aim of this study was to evaluate the potential benefit of intraocular pressure (IOP) reduction in normaltension glaucoma (NTG) Asian adult patients in South Korea. Methods: This was a retrospective, multicenter analysis of 166 NTG Asian adult patients in South Korea. The patient population consisted of Korean patients with NTG with at least 5 years of records available for evaluation. Patients all had typical glaucomatous optic-disc and/or visual-field changes but had never had a recorded IOP >21 mmHg. Results: Overall, 48 (29%) patients were progressed and 116 (71%) were stable over the follow-up period. Of patients with IOPs ≤14mmHg (21/93), 23% progressed and ≥15mmHg (27/73) 37% progressed (P = 0.041). The mean IOP for the stable group was 14.0 ± 1.8 mmHg, whereas with the progressed group the average mean IOP was 14.4 ± 1.6 mmHg (P = 0.20). The mean peak IOP was 17.4 ± 2.2 mmHg in the stable group and 17.8 ± 2.0 mmHg in the progressed group (P = 0.26). Multivariate linear regression analysis did not any identify independent risk factors for progression, including age, gender, or mean and peak IOP. Conclusions: This study provides initial evidence that Korean patients with normal-tension glaucoma, treated to lower IOPs, may have a decreased incidence of progression over 5 years than those patients with higher IOPs. More research is required to confirm this finding.

Original languageEnglish
Pages (from-to)91-96
Number of pages6
JournalJournal of Ocular Pharmacology and Therapeutics
Volume25
Issue number1
DOIs
Publication statusPublished - 2009 Feb 1

Fingerprint

Low Tension Glaucoma
Republic of Korea
Intraocular Pressure
Glaucoma
Optic Disk
Visual Fields
Linear Models
Regression Analysis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Ophthalmology
  • Pharmacology

Cite this

Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea. / Je Seong, Gong; Rho, Sae Heun; Sik Kim, Chang; Moon, Jong Il; Kook, Michael Scott; Kim, Yong Yeon; Tak Ma, Kyoung; Jae Hong, Young; Nelson, Lindsay A.; Kruft, Bonnie; Stewart, Jeanette A.; Stewart, William C.

In: Journal of Ocular Pharmacology and Therapeutics, Vol. 25, No. 1, 01.02.2009, p. 91-96.

Research output: Contribution to journalArticle

Je Seong, G, Rho, SH, Sik Kim, C, Moon, JI, Kook, MS, Kim, YY, Tak Ma, K, Jae Hong, Y, Nelson, LA, Kruft, B, Stewart, JA & Stewart, WC 2009, 'Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea', Journal of Ocular Pharmacology and Therapeutics, vol. 25, no. 1, pp. 91-96. https://doi.org/10.1089/jop.2008.0056
Je Seong, Gong ; Rho, Sae Heun ; Sik Kim, Chang ; Moon, Jong Il ; Kook, Michael Scott ; Kim, Yong Yeon ; Tak Ma, Kyoung ; Jae Hong, Young ; Nelson, Lindsay A. ; Kruft, Bonnie ; Stewart, Jeanette A. ; Stewart, William C. / Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea. In: Journal of Ocular Pharmacology and Therapeutics. 2009 ; Vol. 25, No. 1. pp. 91-96.
@article{57d67d5fa2f442baa5b0076e9edb570d,
title = "Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea",
abstract = "Purpose: The aim of this study was to evaluate the potential benefit of intraocular pressure (IOP) reduction in normaltension glaucoma (NTG) Asian adult patients in South Korea. Methods: This was a retrospective, multicenter analysis of 166 NTG Asian adult patients in South Korea. The patient population consisted of Korean patients with NTG with at least 5 years of records available for evaluation. Patients all had typical glaucomatous optic-disc and/or visual-field changes but had never had a recorded IOP >21 mmHg. Results: Overall, 48 (29{\%}) patients were progressed and 116 (71{\%}) were stable over the follow-up period. Of patients with IOPs ≤14mmHg (21/93), 23{\%} progressed and ≥15mmHg (27/73) 37{\%} progressed (P = 0.041). The mean IOP for the stable group was 14.0 ± 1.8 mmHg, whereas with the progressed group the average mean IOP was 14.4 ± 1.6 mmHg (P = 0.20). The mean peak IOP was 17.4 ± 2.2 mmHg in the stable group and 17.8 ± 2.0 mmHg in the progressed group (P = 0.26). Multivariate linear regression analysis did not any identify independent risk factors for progression, including age, gender, or mean and peak IOP. Conclusions: This study provides initial evidence that Korean patients with normal-tension glaucoma, treated to lower IOPs, may have a decreased incidence of progression over 5 years than those patients with higher IOPs. More research is required to confirm this finding.",
author = "{Je Seong}, Gong and Rho, {Sae Heun} and {Sik Kim}, Chang and Moon, {Jong Il} and Kook, {Michael Scott} and Kim, {Yong Yeon} and {Tak Ma}, Kyoung and {Jae Hong}, Young and Nelson, {Lindsay A.} and Bonnie Kruft and Stewart, {Jeanette A.} and Stewart, {William C.}",
year = "2009",
month = "2",
day = "1",
doi = "10.1089/jop.2008.0056",
language = "English",
volume = "25",
pages = "91--96",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea

AU - Je Seong, Gong

AU - Rho, Sae Heun

AU - Sik Kim, Chang

AU - Moon, Jong Il

AU - Kook, Michael Scott

AU - Kim, Yong Yeon

AU - Tak Ma, Kyoung

AU - Jae Hong, Young

AU - Nelson, Lindsay A.

AU - Kruft, Bonnie

AU - Stewart, Jeanette A.

AU - Stewart, William C.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Purpose: The aim of this study was to evaluate the potential benefit of intraocular pressure (IOP) reduction in normaltension glaucoma (NTG) Asian adult patients in South Korea. Methods: This was a retrospective, multicenter analysis of 166 NTG Asian adult patients in South Korea. The patient population consisted of Korean patients with NTG with at least 5 years of records available for evaluation. Patients all had typical glaucomatous optic-disc and/or visual-field changes but had never had a recorded IOP >21 mmHg. Results: Overall, 48 (29%) patients were progressed and 116 (71%) were stable over the follow-up period. Of patients with IOPs ≤14mmHg (21/93), 23% progressed and ≥15mmHg (27/73) 37% progressed (P = 0.041). The mean IOP for the stable group was 14.0 ± 1.8 mmHg, whereas with the progressed group the average mean IOP was 14.4 ± 1.6 mmHg (P = 0.20). The mean peak IOP was 17.4 ± 2.2 mmHg in the stable group and 17.8 ± 2.0 mmHg in the progressed group (P = 0.26). Multivariate linear regression analysis did not any identify independent risk factors for progression, including age, gender, or mean and peak IOP. Conclusions: This study provides initial evidence that Korean patients with normal-tension glaucoma, treated to lower IOPs, may have a decreased incidence of progression over 5 years than those patients with higher IOPs. More research is required to confirm this finding.

AB - Purpose: The aim of this study was to evaluate the potential benefit of intraocular pressure (IOP) reduction in normaltension glaucoma (NTG) Asian adult patients in South Korea. Methods: This was a retrospective, multicenter analysis of 166 NTG Asian adult patients in South Korea. The patient population consisted of Korean patients with NTG with at least 5 years of records available for evaluation. Patients all had typical glaucomatous optic-disc and/or visual-field changes but had never had a recorded IOP >21 mmHg. Results: Overall, 48 (29%) patients were progressed and 116 (71%) were stable over the follow-up period. Of patients with IOPs ≤14mmHg (21/93), 23% progressed and ≥15mmHg (27/73) 37% progressed (P = 0.041). The mean IOP for the stable group was 14.0 ± 1.8 mmHg, whereas with the progressed group the average mean IOP was 14.4 ± 1.6 mmHg (P = 0.20). The mean peak IOP was 17.4 ± 2.2 mmHg in the stable group and 17.8 ± 2.0 mmHg in the progressed group (P = 0.26). Multivariate linear regression analysis did not any identify independent risk factors for progression, including age, gender, or mean and peak IOP. Conclusions: This study provides initial evidence that Korean patients with normal-tension glaucoma, treated to lower IOPs, may have a decreased incidence of progression over 5 years than those patients with higher IOPs. More research is required to confirm this finding.

UR - http://www.scopus.com/inward/record.url?scp=61749084977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61749084977&partnerID=8YFLogxK

U2 - 10.1089/jop.2008.0056

DO - 10.1089/jop.2008.0056

M3 - Article

VL - 25

SP - 91

EP - 96

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 1

ER -